How Boehringer Ingelheim Deepened Its Digital Transformation
While many pharma companies have integrated digital tools like cloud services into their operations, some are later adopters. Boehringer Ingelheim is one of the most recent companies to announce a move to a cloud-based R&D platform as part of the company’s commitment to digital transformation. For those still considering how to go about the shift to digital, rolling things out in the right order is one important factor, an EY expert tells In Vivo.
You may also be interested in...
Boehringer Ingelheim’s corporate senior vice president, head of global regions, Timmo Rousku Andersen, outlines at a recent summit the company’s reshaped approach to digital innovation and the need to entrench an execution bias to scale transformation initiatives.
Startup financing may be hard to come by, but now is not the time to ask for less cash.
As Bayer moves through a challenging period, business development, licensing and impact investment may help buttress the company’s resilience.